TPH1 and cholangiocarcinoma: In light of the oncogenic potential of serotonin and the dysregulated serotonin metabolic pathway in CCA, particularly the increased expression of TPH1 resulting in elevated serotonin accumulation and secretion, our study emphasizes the therapeutic potential of TE.